GLP-1 recall 2026: is my tirzepatide recalled?
Free recall checker for GLP-1 shots and peptides, from FDA recall records.
By the Peptide Science Desk Editorial TeamFact-checked against FDA and official sources · Not yet reviewed by a licensed clinician. How we check facts
Tirzepatide: Carolina Infusion
5 products in this recall. See all under "Dates and details".
Why: Lack of Assurance of Sterility: Related to formulation using bacteriostic water; Related to processing equipment used in compounded product.
Lots: 07212026@18, 07222026@14, 07292026@8, 08052026@14, 08142026@1, 08192026@10, 08242026@25, 08282026@2, 08292026@1, 07212026@9, 07252026@2, 08122026@14, 08272026@8, 08312026@18, 07252026@3, 08112026@5, 08212026@21, 08282026@3, 08032026@23, 08172026@19, 08262026@13, 09012026@3, 08032026@16, 08052026@8, 08072026@13
Tirzepatide: Apothecary Pharma
Tirzepatide Injection, 18mg/mL, 4 mL Sterile Multi-Dose Vial, Rx only, Apothecary Pharma, LLC, 1913 Evans Road, Cary, NC 27513, NDC 85091-001-18.
Why: Lack of Assurance of Sterility
Lots: AP-202622, AP-202623, AP-202624, AP-202625, AP-202627, AP-202628, AP-202629, AP-202630, AP-202631, AP-202632, AP-202633, AP-202634, AP-202635, AP-202636, AP-202637, AP-202638, AP-202639, AP-202640, AP-202641, AP-202642, AP-202643, AP-202644
Semaglutide: Carolina Infusion
3 products in this recall. See all under "Dates and details".
Why: Lack of Assurance of Sterility: Related to formulation using bacteriostic water; Related to processing equipment used in compounded product.
Lots: 07242026@1, 08032026@20, 08312026@16, 08242026@28, 08072026@16, 07282026@3, 08252026@9, 08042026@12, 08072026@15, 08262026@6
NAD+ (not a peptide): Apothecary Pharma
Apothecary NAD+ Injection 200 mg/mL, 6 mL Sterile Multi-Dose Vial, Rx Only, Apothecary Pharma, LLC, 1913 Evans Road, Cary, NC, 27513, NDC 85091-011-06.
Why: Lack of Assurance of Sterility
Lots: AP-202647
Sermorelin: Carolina Infusion
SERMORELIN ACETATE 1 MG/ML INJECTABLE, Packaged in single-use dosage syringes, total mL dispensed based on dosage per specific patient prescription, Carolina Infusion LLC, 95 Bees Creek Road, Ridgeland
Why: Lack of Assurance of Sterility: Related to formulation using bacteriostic water; Related to processing equipment used in compounded product.
Lots: 07292026@12, 07302026@7
Glutathione: Greenwich Rx
Compounded Glutathione Injection 200 mg/mL, 10 mL multi-dose vials (for under-the-skin use)
Why: Potential elevated endotoxin levels
Lots: 0060-062426-1, 0060-062726-1, 0060-070926-1, 0060-071426-1, 0060-071426-2, 0060-072026-1, 0060-072726-1, 0060-072926-1, 0060-073126-1, 0060-080426-1
Exenatide: Amneal Pharmaceuticals of New York
Exenatide Injection, USP, 250 mcg/mL, 1.2 mL per prefilled pen, Rx Only, Subcutaneous Use Only, For Single Patient Use Only, Manufactured by: Amneal Pharmaceuticals Pvt. Ltd., Ahmedabad 382213, India; Distributed by: Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807, NDC 70121-1685-1
Why: Defective Delivery System: Possibility of no medication in the prefilled pen.
Lots: AP250095A
Glutathione: Centric Compounding
Compounded Glutathione 200 mg/mL, 30 mL multi-dose vials (also Myer’s Cocktail and Tri-Immune Boost vials made with the same glutathione)
Why: Elevated endotoxin level (the glutathione raw ingredient)
Lots: 062326:B, 070826:A, 072726:D, 070226:D, 072126:A, 071626:B
Glutathione: Optimal Balance Pharmacy
Glutathione 200 mg/mL, 30 mL sterile multidose vial, Each vial contains: Glutathione, Ascorbic Acid, Benzyl Alcohol & sterile water for injection, For IM or IV Injection Use Only, RX only, Optimal Balance Pharmacy, 2204 Cypress Creek Pkwy Suite F, Houston, TX 77090
Why: Microbial Contamination of Sterile Products - out of specifications results were obtained for bacterial endotoxin.
Lots: LG342009076
Semaglutide: Apollo Care
11 products in this recall. See all under "Dates and details".
Why: Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material
Lots: AC-017273, AC-017108, AC-017110, AC-017112, AC-017142, AC-017144, AC-017166, AC-017167, AC-017177, AC-017213, AC-017224, AC-017225, AC-017114, AC-017164, AC-017204, AC-017205, AC-017271, C-017115, AC-017163, AC-017169, AC-017170, AC-017171, AC-017230, AC-017231, AC-017131, AC-017275, AC-017282, AC-017285, AC-017274, AC-017125, AC-017138, AC-017147, AC-017214, AC-017226, AC-017228, AC-017124, AC-017136, AC-017272
Glutathione: Victory Medical Center Pharmacy
Glutathione (MDV), 200 mg/mL, 30 mL vial, each mL contains Glutathione 200 mg, Ascorbic Acid 20 mg, Benzyl Alcohol 1.5%, Na Hydroxide (Ph Adjust) in sterile water for injection, VMC.
Why: Microbial Contamination of Sterile Products - out of specifications results were obtained for bacterial endotoxin.
Lots: 1984345, 1980571, 1981940
Liraglutide: Lupin Pharmaceuticals
Liraglutide Injection, 18 mg/3 mL (6 mg/mL), Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Naples, FL 34108, Manufactured by: Lupin Limited, Nagpur 441108, INDIA, a) 2 Pens- NDC 70748-346-02; b) 3 Pens - NDC 70748-346-03.
Why: Presence of particulate matter: a white thread-like structure in the cartridge
Lots: WB00097, WB00094, WB00088, WB00103, WC00016, WB00098, WB00092, WB00093, WB00104, WB00106, WB00105
Semaglutide: Payless Compounders
Semaglutide-Glycine-Cyanocobalamin Injectable, 2.5 mg, 5 mg, 1 MG/ML, 0.5 mL vials, Rx only, Northwest Compounders, Beaverton, OR
Why: Lack of Assurance of Sterility
Lots: 01-27-2026@14S.5
Tirzepatide: New Life Pharma
2 products in this recall. See all under "Dates and details".
Why: Lack of Assurance of Sterility
Lots: 240709
Semaglutide: Harbin Jixianglong Biotech
2 products in this recall. See all under "Dates and details".
Why: CGMP Deviations This recall has been initiated due to failing to complete process validation and bacterial endotoxin method validation before distribution
Lots: CP-030-20250911, CP-030-20250711
Semaglutide: New Life Pharma
2 products in this recall. See all under "Dates and details".
Why: Lack of Assurance of Sterility
Lots: 240903, 241113, 250103
Semaglutide: Novo Nordisk
2 products in this recall. See all under "Dates and details".
Why: Presence of Particulate Matter: Hair was found in a prefilled syringe
Lots: RZFYK06, RZFYA53, RZFHD52, RZFHW93
Our list: 17 recalls (37 products, 141 lot numbers), from FDA records checked Oct 21, 2026. FDA Enforcement Report data was last updated Oct 14, 2026. Not on our list? Also search the FDA Enforcement Report.
Peptide and GLP-1 recalls we track
37 recall records from FDA reports, by drug, by reason, and by how serious
By drug
- Semaglutide 21
- Tirzepatide 8
- Glutathione 4
- NAD+ 1
- Sermorelin 1
- Exenatide 1
- Liraglutide 1
By reason
- No proof it was sterile 16
- Bits floating inside 14
- Germ toxins (endotoxin) 2
- Germs found 2
- Factory rules not followed 2
- Pen might be empty 1
By how serious (FDA class)Class I is the most serious
- Class II 33
- Not classed yet 2
- Class I 2
Most recalls were for compounded copies, mainly because no one could prove they were sterile.
Show the numbers as a table
| Grouped by | Breakdown | Total |
|---|---|---|
| By drug | Semaglutide: 21; Tirzepatide: 8; Glutathione: 4; NAD+: 1; Sermorelin: 1; Exenatide: 1; Liraglutide: 1 | 37 |
| By reason | No proof it was sterile: 16; Bits floating inside: 14; Germ toxins (endotoxin): 2; Germs found: 2; Factory rules not followed: 2; Pen might be empty: 1 | 37 |
| By how serious (FDA class) | Class II: 33; Not classed yet: 2; Class I: 2 | 37 |
What to do if your GLP-1 is recalled
- Stop using itThe recall notices tell people to stop using recalled vials. Do not use it again until you have talked to the pharmacy or your prescriber.
- Call the pharmacy and your prescriberAsk how to return or throw away the vial, and what to use instead. Do not stop a medicine your doctor prescribed without asking them.
- Get care if you feel sickIf you feel sick after a shot, get medical help. Tell them what you used and show them the label.
- Report it to the FDAAnyone can report a problem to FDA MedWatch, online or by phone at 1-800-332-1088.
Which tirzepatide was recalled in October 2026?
- Apothecary Pharma LLC (Cary, North Carolina) recalled 22 vials of tirzepatide injection, 18 mg/mL, 4 mL multi-dose vials.
- Lots AP-202622 to AP-202644. Lot AP-202626 is not on the FDA list. Beyond-use dates run from October 7 to November 26, 2026.
- Reason: "lack of assurance of sterility." The recall started September 24, 2026. FDA classified it as Class II on October 8, 2026, and listed it in its October 14 Enforcement Report.
- The same recall lists 1 vial of NAD+ injection (lot AP-202647). NAD+ is not a peptide.
- FDA also lists a Class II recall from Carolina Infusion LLC (Ridgeland, South Carolina) of pharmacy-made tirzepatide, semaglutide, and sermorelin syringes, classified the same day.
What is a Class 2 recall?
| Recall class | What FDA says it means |
|---|---|
| Class I | The most serious. FDA says there is a reasonable chance the product will cause serious health problems or death. |
| Class II | FDA says the product may cause short-term or medically reversible health problems, or the chance of serious harm is remote. |
| Class III | FDA says the product is not likely to cause health problems. |
The company runs the recall. FDA classifies it and posts it in its weekly Enforcement Report.
Are compounded GLP-1s safe?
Compounded GLP-1 drugs are not FDA approved. The FDA does not check them for safety, effectiveness, or quality before they are sold. That is a separate question from whether one batch was recalled.
Most recalls in our list are pharmacy-made shots. Most were for sterility problems, particles in the liquid, or endotoxins (bits of bacteria that can cause fever).
Is compounded semaglutide safe? · Compounded tirzepatide vs Zepbound
FAQ
Is Zepbound or Mounjaro being recalled?
We found no 2026 recall of Zepbound or Mounjaro in FDA’s Enforcement Report data (last updated October 14, 2026). The tirzepatide recalls we found were pharmacy-made versions. Brand-name Wegovy had a small 2-lot recall in January 2026, listed in the tool.
What does "lack of assurance of sterility" mean?
It means the maker could not show that the product was made in a way that keeps germs out. It does not always mean germs were found. Shots must be sterile, so it still matters.
My lot is not on the list. Does that mean it is safe?
No. It only means it does not match the recalls in our list. New recalls can be posted at any time, and our list covers only GLP-1 drugs and peptides. Check the FDA links on this page, too.
Where is the lot number?
Look on the vial or box label for "Lot." Pharmacy-made drugs often show a "BUD" (beyond-use date) instead of an expiration date. Lot numbers can mix letters, numbers, dashes, and @ signs, like AP-202630 or 07212026@18. Type it exactly as printed.
Is NAD+ a peptide?
No. NAD+ is made of 2 nucleotides, not amino acids. We include it only because it is in the same Apothecary Pharma recall. Glutathione is different: it is a tiny chain of 3 amino acids (a tripeptide).
Does a recall mean the pharmacy is closed?
No. A recall covers the products and lots listed. It does not say anything about other products by itself.
Is my search saved or sent?
No. The checker runs in your browser. Nothing you type is saved or sent to us.
Related pages
- Online GLP-1 providers comparedTool
- GLP-1: what it is, drugs list and side effectsGLP-1 guide
- Compounded tirzepatide vs ZepboundGuide
- Is compounded semaglutide safe?Guide
- Is my peptide source legit?Tool
- Do peptides expire?Guide
- GLP-1: Zepbound / Mounjaro (tirzepatide)Peptide page
- GLP-1: Wegovy / Ozempic (semaglutide)Peptide page
- News: compounded tirzepatide recallNews
- FDA interim peptide policy explainedGuide
Sources
- FDA Enforcement Report (search all drug recalls by firm, product or lot)
- openFDA: Drug Enforcement Report data (records used here; data last updated Oct 14, 2026)
- openFDA record: Apothecary Pharma LLC recall, event 99952 (tirzepatide and NAD+, Class II, classified Oct 8, 2026)
- openFDA record: Carolina Infusion LLC recall, event 99867 (Class II, classified Oct 8, 2026)
- FDA: Drug recalls (company announcements)
- FDA: Greenwich Rx recall of compounded glutathione (Oct 1, 2026)
- FDA: Centric Compounding recall of glutathione, Myer’s Cocktail and Tri-Immune Boost (Sept 13, 2026)
- FDA: Recalls background and definitions (Class I, II, III)
- FDA MedWatch: report a problem
- FDA: Concerns with unapproved GLP-1 drugs used for weight loss
- PubChem: Glutathione (a tripeptide)
- PubChem: NAD (nicotinamide adenine dinucleotide)